EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 299 filers reported holding EXELIXIS INC in Q1 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $700,756,157 | +11.7% | 32,071,220 | -2.3% | 0.02% | +13.3% |
Q2 2023 | $627,360,567 | -2.4% | 32,828,915 | -0.9% | 0.02% | -6.2% |
Q1 2023 | $642,844,254 | +24.1% | 33,119,230 | +2.6% | 0.02% | +14.3% |
Q4 2022 | $517,915,784 | +5.6% | 32,289,014 | +3.2% | 0.01% | 0.0% |
Q3 2022 | $490,546,000 | -24.2% | 31,284,832 | +0.7% | 0.01% | -22.2% |
Q2 2022 | $646,768,000 | -5.7% | 31,064,733 | +2.6% | 0.02% | +12.5% |
Q1 2022 | $686,193,000 | +24.9% | 30,268,772 | +0.7% | 0.02% | +33.3% |
Q4 2021 | $549,490,000 | -13.7% | 30,059,689 | -0.2% | 0.01% | -25.0% |
Q3 2021 | $636,422,000 | +16.6% | 30,105,074 | +0.5% | 0.02% | +14.3% |
Q2 2021 | $545,596,000 | -17.9% | 29,944,880 | +1.9% | 0.01% | -22.2% |
Q1 2021 | $664,149,000 | +16.2% | 29,400,178 | +3.3% | 0.02% | +5.9% |
Q4 2020 | $571,394,000 | -15.9% | 28,470,067 | +2.4% | 0.02% | -22.7% |
Q3 2020 | $679,486,000 | -0.5% | 27,790,831 | -3.4% | 0.02% | -8.3% |
Q2 2020 | $683,111,000 | +37.3% | 28,774,747 | -0.4% | 0.02% | +14.3% |
Q1 2020 | $497,702,000 | +0.5% | 28,902,587 | +2.8% | 0.02% | +23.5% |
Q4 2019 | $495,318,000 | -0.3% | 28,111,171 | +0.0% | 0.02% | -5.6% |
Q3 2019 | $496,962,000 | -16.3% | 28,100,810 | +1.2% | 0.02% | -18.2% |
Q2 2019 | $593,470,000 | -10.1% | 27,771,161 | +0.1% | 0.02% | -15.4% |
Q1 2019 | $660,064,000 | +22.8% | 27,733,773 | +1.5% | 0.03% | +8.3% |
Q4 2018 | $537,692,000 | +14.4% | 27,335,719 | +3.0% | 0.02% | +33.3% |
Q3 2018 | $470,060,000 | -15.0% | 26,527,089 | +3.2% | 0.02% | -21.7% |
Q2 2018 | $552,905,000 | -3.7% | 25,692,611 | -0.9% | 0.02% | -8.0% |
Q1 2018 | $574,390,000 | -28.3% | 25,931,816 | -1.6% | 0.02% | -28.6% |
Q4 2017 | $801,097,000 | +28.2% | 26,351,871 | +2.2% | 0.04% | +20.7% |
Q3 2017 | $624,818,000 | -0.3% | 25,786,961 | +1.4% | 0.03% | -6.5% |
Q2 2017 | $626,635,000 | +21.8% | 25,441,964 | +7.2% | 0.03% | +19.2% |
Q1 2017 | $514,339,000 | +64.0% | 23,735,071 | +12.8% | 0.03% | +52.9% |
Q4 2016 | $313,680,000 | +42.2% | 21,038,194 | +21.9% | 0.02% | +30.8% |
Q3 2016 | $220,651,000 | +71.7% | 17,251,858 | +4.8% | 0.01% | +62.5% |
Q2 2016 | $128,536,000 | +99.8% | 16,457,824 | +2.3% | 0.01% | +100.0% |
Q1 2016 | $64,328,000 | -27.0% | 16,082,070 | +3.0% | 0.00% | -33.3% |
Q4 2015 | $88,094,000 | -77.4% | 15,619,701 | -57.7% | 0.01% | -60.0% |
Q3 2015 | $389,167,000 | +670.2% | 36,903,486 | +174.6% | 0.02% | +400.0% |
Q2 2015 | $50,525,000 | +66.4% | 13,437,322 | +13.7% | 0.00% | +50.0% |
Q1 2015 | $30,361,000 | +91.0% | 11,813,513 | +7.0% | 0.00% | +100.0% |
Q4 2014 | $15,895,000 | -3.0% | 11,038,706 | +3.1% | 0.00% | 0.0% |
Q3 2014 | $16,389,000 | -55.8% | 10,711,792 | -2.1% | 0.00% | -66.7% |
Q2 2014 | $37,108,000 | -4.9% | 10,946,386 | -0.7% | 0.00% | 0.0% |
Q1 2014 | $39,022,000 | -37.2% | 11,023,163 | +8.7% | 0.00% | -40.0% |
Q4 2013 | $62,143,000 | +8.7% | 10,137,461 | +3.2% | 0.01% | -16.7% |
Q3 2013 | $57,182,000 | +29.0% | 9,825,106 | +0.6% | 0.01% | +20.0% |
Q2 2013 | $44,331,000 | – | 9,764,340 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |